Brief: Resonance Health Says Contracted By VGI Health Technology For Nash Phase II Clinical Study
25/01/2022 02:00
Jan 25 (Reuters) - Resonance Health Ltd RHT.AX :
* RESONANCE HEALTH LTD - CONTRACTED BY VGI HEALTH TECHNOLOGY
LTD
FOR NASH PHASE II CLINICAL STUDY
Source text for Eikon: ID:nASX3N29F6
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co